The global nucleic acid labeling market size is expected to reach USD 3.22 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.81% from 2020 to 2027. Technological advancements with respect to PCR, DNA sequencing, nanotechnology, and microfluidics are expected to help enhance the market potential in the near future. Additionally, nucleic acid labeling products are gaining significant momentum across diagnostic as well as therapeutic interventions associated with cancer disorders and genetic deformities, thereby elevating the market growth.
Technologies
that enable direct detection of specific sequences of RNA or DNA serve as
occasional potent alternatives to amplification protocols employed in gene
expression studies. Research activities performed on these lines have also led
to the development of novel label protocols such as that of incorporating
probes that are specifically labeled with anti-label antibodies conjugated via
alkaline phosphatase. This direct detection technique employing the use of
specific labeled probes has emerged as a reliable and flexible approach for
gene expression analysis, well-suited for high-throughput screening.
The
continuing quest for designing labels with enhanced functional properties
suitable for hybridization assays has led to the introduction of an array of
potential approaches to label nucleic acids that are inclusive of genes
encoding enzymes, microparticles, and a novel class of fluorophores.
With
the emergence of novel viral infections, such as the coronavirus (COVID 19),
followed by the MERS outbreak in 2015 and the SARS outbreak in 2003, healthcare
professionals are experiencing a significant urge for the development of rapid
detection approaches that can assist in the identification of target viruses at
scale. The COVID-19 pandemic has also led to an increase in demand for nucleic
acid-based research efforts aimed at developing breakthrough treatment
solutions, further expected to accelerate market expansion.
For
more info visit here: https://www.grandviewresearch.com/industry-analysis/nucleic-acid-labeling-market
Nucleic
Acid Labeling Market Report Highlights
- By product,
the reagents segment dominated the market in 2019 and is set to maintain
its lead throughout the forecast period. This is attributed to the fact
that reagents are essential components across both enzymatic and chemical
labeling, resulting in an expanding vendor base aimed at introducing novel
and effective reagents to label DNA/RNA
- By labeling
type, the radioactive or radioisotope labels dominated the market in 2019
and are anticipated to maintain their lead throughout the forecast period.
Radioactive labeling is gaining increased traction among the
professionals, which is further supplemented by the ease of incorporation
of radioactively labeled nucleic acid sequences
- The
oligonucleotide application segment is expected to grow at the fastest pace
from 2020 to 2027. The end labeling of oligonucleotides with radioisotopes
has gained immense traction over the years. This is attributed to the fact
that such oligonucleotides are set to drive the nucleic acid probe
technology, which can be custom made via the information on target RNA and
DNA
- North America
captured the largest share of 39.47% in 2019, which is primarily
attributed to the expanding portfolios of emerging manufacturers, along
with robust support from research organizations, collectively contributing
to the regional revenue
- Companies are
engaged in acquisitions and collaborations to maintain a competitive edge
in the market
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment